Skip to main content
. 2020 Oct 15;138(12):1253–1261. doi: 10.1001/jamaophthalmol.2020.4231

Table 2. Distribution of Distance Visual Acuity Scores for Affected Eyes at Enrollment and 6 Months.

Variable VA, No. (%)a
High contrast Low contrast
Enrollment (n = 54) 6 mo (n = 45) Enrollment (n = 54) 6 mo (n = 42)
VA in affected eyes, Snellen equivalent (No. of letters)
Worse than 20/800 (0-2 letters)b 16 (30) 1 (2) 33 (61) 6 (14)
20/250 to 20/800 (3-32) 12 (22) 1 (2) 13 (24) 3 (7)
20/50 to 20/200 (33-67) 10 (19) 5 (11) 6 (11) 25 (60)
20/20 to 20/40 (68-83) 12 (22) 22 (49) 2 (4) 8 (19)
Better than 20/20 (≥88) 4 (7) 16 (36) 0 (0) 0 (0)
Mean logMAR VA (95% CI)c 0.95 (0.75 to 1.16) 0.12 (−0.01 to 0.26) 1.49 (1.36 to 1.61) 0.73 (0.56 to 0.90)
Age-normal VA, No. (%) [95% CI]c 11 (20) [11 to 33] 34 (77) [61 to 88] NA NA
Change in VA from enrollment (logMAR lines)
≥13 Lines better NA 15 (33) NA 7 (17)
9-12 Lines better 6 (13) 14 (33)
5-8 Lines better 4 (9) 7 (17)
2-4 Lines better 9 (20) 3 (7)
Within 1 line 9 (20) 10 (24)
≥2 Lines worse 2 (4) 1 (2)
Mean change (95% CI), logMARc,d 0.76 (0.54 to 0.99) 0.72 (0.54 to 0.89)
Different test method used from enrollment 7 (16) 7 (17)

Abbreviations: NA, not available; VA, visual acuity.

a

Values are expressed as No. (%) unless otherwise specified.

b

LogMAR converted to Snellen as follows: –0.2 = 20/12; –0.1 = 20/16; 0 = 20/20; 0.1 = 20/25; 0.2 = 20/32; 0.3 = 20/40; 0.4 = 20/50; 0.5 = 20/63; 0.6 = 20/80; 0.7 = 20/100; 0.8 = 20/125; 0.9 = 20/160; 1 = 20/200; 1.1 = 20/250; 1.2 = 20/320; 1.3 = 20/400; 1.4 = 20/500; 1.5 = 20/640; 1.6 = 20/800; 1.7 = <20/800.

c

Adjusted for intereye correlation.

d

Positive values indicate improvement in amblyopic-eye visual acuity.